CALGARY, Alberta, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Voyageur Minerals Ltd. (TSXV:VM) (the “Company”), is pleased to announce that it has continued to intersect a large barite breccia vein in 100% of the drilling to date.
The latest lab results show an average width of 20.37m across 60m of strike with a weighted average of 30.57% BaSO4 along the explored portion of the breccia vein.
The highlights of the latest drill results:-
- FC17-09 intersected 36.03m true width at 19.47% BaSO4.
- FC17-10 intersected 11.86m true width at 60.32% BaSO4.
- FC17-11 intersected 23.88m true width at 27.05% BaSO4.
- FC17-12 intersected 18.7m true width at 37.39% BaSO4.
- FC17-13 intersected 22.88m true width at 23.94% BaSO4.
- FC17-14 intersected 14m true width at 38.41% BaSO4.
- FC17-15 intersected 15.22m true width at 37.65% BaSO4.
The drill intercept from FC17-13, included an interval from 29.6 – 30.1m that assayed 99.09% BaSO4, which is exceptionally pure and is pharmaceutical grade.
To date Voyageur has completed 17 drill holes with further assays pending, drilling is on-going, with a second shift is being added to maximize drilling results.
The next phase of drilling will be to continue on strike, with goals of adding resources and connecting the A and B zone as one structure. An NI 43-101 report will be initiated at the completion of this next phase of drilling. Drill holes FC17-09, 10, 11 and 12 were drilled from the same drill station and were fanned across the strike of the zone. Drill hole’s FC17-13, 14 and 15 were drilled at a second location 25m down strike and 15m lower in elevation. Drilling is designed to fan across the strike to build the initial near surface resources from surface to 60m depths.
The crystalline barite is consistent throughout the breccia and a pure barite sample from drill hole FC17-15 29.6m-30.1m assayed at 99.09% BaSO4. This reflects the purity of the barite matrix within the breccia. Assays were performed at Loring Labs of Calgary, AB., an ISO – 9001 -2017 accredited commercial laboratory.
The barite breccia vein contains crystalline barite with grades up to 99.49% BaSO4 in the breccia matrix. Testing to date indicates that the crystalline barite is exceptionally pure and may qualify for the pharmaceutical market. Additional select samples will be taken from the core of other drill holes to test the purity of the crystalline barite throughout the vein.
Voyageur’s management believes that a high quality predominately crystalline barite product can be produced from the Frances Creek Vein by gravity separation milling. Future metallurgical testing will be conducted to test management’s theory.
Drilling Results
| Hole Number | Hole Depth | Barite Intersection | %BaSO4 | Specific Gravity | True Width | True Width Ba Zone | Total %BaSO4 Ba Zone |
| FC17-09 | 73.5m | 15.0m-24.7m | 40.29% | 3.27 | 8.58m | 36.03m | 19.47% |
| FC17-09 | 28.8m-30.6m | 10.43% | 2.94 | 1.6m | |||
| FC17-09 | 35.5m-38.3m | 20.80% | 3.05 | 2.49m | |||
| FC17-09 | 42.5m-55.5m | 24.85% | 3.09 | 11.56m | |||
| FC17-10 | 34m | 17.6m-33.6m | 60.32% | 3.46 | 11.86m | 11.86m | 60.32% |
| FC17-11 | 74m | 22.2m-26.7m | 26.37% | 3.13 | 2.64m | 23.88m | 24.96% |
| FC17-11 | 32.7m-42.9m | 40.50% | 3.33 | 5.8m | |||
| FC17-11 | 43.4m-45.3m | 75.96% | 3.83 | 1.08m | |||
| FC17-11 | 45.3m-47.3m | 51.39% | 3.33 | 1.14m | |||
| FC17-11 | 51.0m-53.2m | 29.59% | 3.11 | 1.26m | |||
| FC17-11 | 61.3m-64.1m | 71.08% | 3.71 | 1.60m | |||
| FC17-12 | 57m | 20.5m-21.5m | 19.03% | 2.98 | 0.48m | 18.70m | 36.80% |
| FC17-12 | 25.0m-32.0m | 20.31% | 2.96 | 4.11m | |||
| FC17-12 | 32.0m-50.3m | 59.79% | 3.51 | 9.37m | |||
| FC17-12 | 50.3m-52.2m | 15.28% | 2.98 | 0.97m | |||
| FC17-12 | 55.0m-57.0m | 30.62% | 3.22 | 1.03m | |||
| FC17-13 | 63m | 20.5m-30.9m | 41.94% | 3.28 | 9.18m | 22.88m | 23.94% |
| FC17-13 | 32.9m-33.2m | 41.63% | 3.34 | 0.264m | |||
| FC17-13 | 41.1m-42.6m | 48.88% | 3.34 | 1.33m | |||
| FC17-13 | 43.7m-44.2m | 17.03% | 2.97 | 0.44m | |||
| FC17-13 | 44.9m-46.4m | 60.03% | 3.47 | 1.32m | |||
| FC17-14 | 63m | 27.9m-33.3m | 55.11% | 3.38 | 3.86m | 14.00m | 38.41% |
| FC17-14 | 36.6m-43.3m | 53.46% | 3.35 | 4.79m | |||
| FC17-14 | 45.9m-47.5m | 57.92% | 3.40 | 1.19m | |||
| FC17-15 | 60m | 21.5m-27.0m | 40.50% | 3.13 | 4.95m | 15.22m | 37.65% |
| FC17-15 | 29.6m-30.1m | 99.09% | 4.49 | 0.45m | |||
| FC17-15 | 30.1m-32.1m | 75.70% | 3.98 | 1.89m | |||
| FC17-15 | 32.1m-32.9m | 95.27% | 4.42 | 0.63m | |||
| FC17-15 | 32.9m-35.7m | 42.67% | 3.18 | 2.52m | |||
| FC17-15 | 38.0m-38.4m | 48.10% | 3.31 | 0.36m |
About Voyageur Minerals
Voyageur is a Calgary based company which owns 100% interest in three barium sulfate ("Barite") deposits including two properties which initial work suggests are suitable in grade for the industrial and pharmaceutical barite market place.
The Company also has interests in two high grade lithium brine projects in Utah, USA. Voyageur's business plan is to develop its Barite deposit at Frances Creek, BC, Canada, for potential near term cash flow, while it continues exploration for critical and strategic minerals.
Qualified Person Statement
The Company’s qualified person as defined by NI 43-101, Mr. Randy Henkle, P.Geol, has reviewed this news release and approved it.
| For further information, please contact | ||
| John Rucci | Steven R. Livingston | |
| President & CEO | VP Finance | |
| (403) 383-8588 | (403) 471-1659 | |
| jrucci@voyageurminerals.ca | steve@voyageurminerals.ca | |
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements relating to the Qualifying Transaction, including statements regarding the acquisition of future assets, the discovery and commercialization of commercial quantities of industrial minerals, the successful commercialization of the Company’s assets, expected operational activities, other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things: the risk that the assets do not provide commercial quantities or grades of marketable minerals, that even if they do contain commercial quantities of marketable minerals that the Company will not be able to economically produce such discoveries, the existence of commercial grades of commercial minerals, timing of obtaining required approvals, state of the economy in general and capital markets in particular, investor interest in the business and future prospects of the Company.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.